Euclidean Capital’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.68M | Hold |
|
|||||
|
2025
Q2 | $2.79M | Hold |
|
|||||
|
2025
Q1 | $2.86M | Hold |
|
|||||
|
2024
Q4 | $3.97M | Hold |
|
|||||
|
2024
Q3 | $3.92M | Hold |
|
|||||
|
2024
Q2 | $4.26M | Hold |
|
|||||
|
2024
Q1 | $4.47M | Hold |
|
|||||
|
2023
Q4 | $8.15M | Hold |
|
|||||
|
2023
Q3 | $16.1M | Buy |
|
|||||
|
2023
Q2 | $15.9M | Buy |
|
|||||
|
2023
Q1 | $11.1M | Hold |
|
|||||
|
2022
Q4 | $20.3M | Hold |
|
|||||
|
2022
Q3 | $27.8M | Hold |
|
|||||
|
2022
Q2 | $33.3M | Hold |
|
|||||
|
2022
Q1 | $48.7M | Hold |
|
|||||
|
2021
Q4 | $54M | Sell |
|
|||||
|
2021
Q3 | $82.5M | Sell |
|
|||||
|
2021
Q2 | $134M | Sell |
|
|||||
|
2021
Q1 | $137M | Hold |
|
|||||
|
2020
Q4 | $257M | Buy |
|